IndraLab

Statements


USP48 inhibits CREBBP. 1 / 1
| 1

reach
"The subcutaneous tumor and intraperitoneally injected experiments demonstrated that the USP48 knockdown significantly increases responsiveness to CBP, and alleviates the metastasis in vivo."